Endocannabinoid pharmacology and hippocampal synaptic plasticity

内源性大麻素药理学和海马突触可塑性

• 批准号: 252016
• 负责人: Zhang Xia
• 金额: $ 60.13万
• 依托单位: University of Ottawa Institute of Mental Health Research
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2012
• 资助国家: 加拿大
• 起止时间: 2012-03-01 至 2017-03-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=252016&lang=en
• 关键词: Behavioral Sciences; Cannabinoid Type 1 Receptor; Eletrophysiology; Endocannabioid Phamacology; G Protein Coupled Receptor; Hippocampus; Long-Term Depression; Long-Term Potentiation; Molecualr Biology; Synaptic Plasticity

This project follows directly from our earlier research and investigates the possibility that naturally occurring cannabinoid compounds in the human brain of the kind found in marijuana can impair and enhance neuronal transmission. The potential medical

该项目直接遵循我们早期的研究，并调查了大麻中发现的人类大脑中天然存在的大麻素化合物可能会损害和增强神经元传递的可能性。 所述潜在医疗